Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

HemaQuest receives orphan medicinal designations for hemoglobin disorders

March 30, 2009

Bristol-Myers Squibb presents novel glucokinase activators

March 30, 2009

Novel diacylglycerol acyltransferase type 1 inhibitors developed by AstraZeneca

March 30, 2009

GlycoMimetics completes two phase I studies for GMI-1070

March 27, 2009

Neurocrine reports top-line results from phase II elagolix trial in endometriosis

March 27, 2009

Exenatide data analysis shows no increased risk of cardiovascular events

March 27, 2009

Regeneron initiates phase III gout program with Arcalyst

March 27, 2009

IMPACT2 shows relief of hereditary angioedema attacks with C1-INH

March 27, 2009

Additional indication for Actos approved in Japan

March 26, 2009

Novel alpha-alkyl substituted N-acyltryptophanols discovered by Bayer Schering Pharma

March 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...